Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity Statement

v3.22.0.1
Consolidated Statements of Stockholders' Equity Statement - USD ($)
$ in Thousands
Total
Common Shares
Additional Paid-In Capital
Accumulated other comprehensive loss
Accumulated Deficit
Balance (in shares) at Dec. 31, 2018   85,500,000      
Balance at Dec. 31, 2018 $ 135,717 $ 488,744 $ 31,869 $ (805) $ (384,091)
Increase (Decrease) in Stockholders' Equity          
Issue of common shares upon public offerings, net of issuance costs 223,118 $ 223,118      
Issuance of common shares (in shares)   19,735,000      
Exercise of warrants 6,988 $ 12,428 (5,440)    
Exercise of warrants (in shares)   2,983,000      
Exercise of stock options $ 13,748 $ 22,197 (8,449)    
Exercise of stock options (in shares) 3,578,000 3,580,000      
Share-based compensation $ 7,414   7,414    
Net loss $ (88,385)       (88,385)
Balance (in shares) at Dec. 31, 2019 111,800,000 111,798,000      
Balance at Dec. 31, 2019 $ 298,600 $ 746,487 25,394 (805) (472,476)
Increase (Decrease) in Stockholders' Equity          
Issue of common shares upon public offerings, net of issuance costs 187,732 $ 187,732      
Issuance of common shares (in shares)   13,333,000      
Exercise of warrants 1 $ 2 (1)    
Exercise of warrants (in shares)   1,000      
Exercise of stock options $ 6,643 $ 10,107 (3,464)    
Exercise of stock options (in shares) 1,593,000 1,593,000      
Share-based compensation $ 17,454   17,454    
Net loss $ (102,680)       (102,680)
Balance (in shares) at Dec. 31, 2020 126,725,000 126,725,000      
Balance at Dec. 31, 2020 $ 407,750 $ 944,328 39,383 (805) (575,156)
Increase (Decrease) in Stockholders' Equity          
Issue of common shares upon public offerings, net of issuance costs 196,740 $ 196,740      
Issuance of common shares (in shares)   10,166,000      
Exercise of warrants 365 $ 2,102 (1,737)    
Exercise of warrants (in shares)   1,434,000      
Exercise of stock options $ 23,421 $ 33,073 (9,652)    
Exercise of stock options (in shares) 3,238,000 3,238,000      
Issuance of common shares in conjunction with ESPP program (in shares)   37,000      
Issued pursuant to ESPP $ 585 $ 808 (223)    
Share-based compensation 31,243   31,243    
Other comprehensive income (47)     (47)  
Net loss $ (180,966)       (180,966)
Balance (in shares) at Dec. 31, 2021 141,600,000 141,600,000      
Balance at Dec. 31, 2021 $ 479,091 $ 1,177,051 $ 59,014 $ (852) $ (756,122)